Andreas Deistung
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Andreas Deistung has a total of 517 co-authors. Here are the top co-authors by number of shared publications:
- Jürgen Rainer Reichenbach
Jena University Hospital
42 shared publications Ferdinand Schweser
Buffalo Neuroimaging Analysis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, The State University of New York, Buffalo, NY, USA
15 shared publications- Alexander Rauscher
Department of Physics and Astronomy, University of British Columbia, Vancouver, British Columbia, Canada
8 shared publications - Ferdinand Schweser
Affiliations Buffalo Neuroimaging Analysis Center, Department of Neurology at the Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, The State University of New York, Buffalo, New York, United States of America, Center for Biomedical Imaging, Clinical and Translational Science Institute, University at Buffalo, The State University of New York, Buffalo, New York, United States of America
8 shared publications Jürgen R. Reichenbach
Medical Physics Group, Institute of Diagnostic and Interventional Radiology, Jena University Hospital, Jena 07743, Germany
8 shared publicationsDagmar Timmann
Center for Translational Neuro- and Behavioral Sciences (C-TNBS), Essen University Hospital, University of Duisburg-Essen, Essen, Germany
7 shared publications
Latest Publications
- Open Access
- 3 November 2026
- Published by Springer Nature in Translational Psychiatry
- Vol. 16 (1) , 608
Temporal cortical gray matter volume relates to symptom improvement during cognitive behavioral therapy for depression
Cognitive behavioral therapy (CBT) is a first-line treatment for depression, yet treatment responses vary considerably. Understanding neurobiological factors associated with symptom improvement may help elucidate mechanisms underlying therapeutic change. This study investigated whether baseline cortical gray matter volume (GMV) is associated with reductions in depressive symptom severity during CBT. Therefore, n = 52 patients with unipolar affective disorders and at least mild depressive symptoms (according to BDI-II) and n = 42 healthy controls underwent clinical assessments and structural MRI at baseline; depressive symptom severity was reassessed after six months of outpatient CBT. Multiple regression analyses examined associations between pre-treatment cortical GMV and reductions in depressive symptoms under false discovery rate (FDR) correction. Additional models included anxiety, perceived stress, and childhood trauma as predictors. Compared to controls, patients exhibited significantly higher depressive symptom severity at baseline and greater symptom reduction over time (all p < 0.001). Within patients, baseline GMV of the right middle temporal gyrus (MTG) was significantly associated with symptom reduction (baseline–follow-up; β = 0.55, p FDR = 0.033). Right MTG volume accounted for additional variance in symptom reduction beyond established clinical variables (Δ R ² = 0.15). Group differences in GMV did not remain significant following FDR correction. These findings suggest that temporal gyrus GMV is associated with symptom improvement following CBT in unipolar depression, extending the focus beyond traditionally emphasized limbic regions. Preserved temporal morphology may support cognitive and emotional processes engaged during CBT, underscoring the relevance of temporal cortical structure for understanding the neurobiological correlates of psychotherapy response.
- 3 November 2026
- Published by Springer Nature in Translational Psychiatry
- Vol. 16 (1) , 608
Open AccessTemporal cortical gray matter volume relates to symptom improvement during cognitive behavioral therapy for depression
Cognitive behavioral therapy (CBT) is a first-line treatment for depression, yet treatment responses vary considerably. Understanding neurobiological factors associated with symptom improvement may help elucidate mechanisms underlying therapeutic change. This study investigated whether baseline cortical gray matter volume (GMV) is associated with reductions in depressive symptom severity during CBT. Therefore, n = 52 patients with unipolar affective disorders and at least mild depressive symptoms (according to BDI-II) and n = 42 healthy controls underwent clinical assessments and structural MRI at baseline; depressive symptom severity was reassessed after six months of outpatient CBT. Multiple regression analyses examined associations between pre-treatment cortical GMV and reductions in depressive symptoms under false discovery rate (FDR) correction. Additional models included anxiety, perceived stress, and childhood trauma as predictors. Compared to controls, patients exhibited significantly higher depressive symptom severity at baseline and greater symptom reduction over time (all p < 0.001). Within patients, baseline GMV of the right middle temporal gyrus (MTG) was significantly associated with symptom reduction (baseline–follow-up; β = 0.55, p FDR = 0.033). Right MTG volume accounted for additional variance in symptom reduction beyond established clinical variables (Δ R ² = 0.15). Group differences in GMV did not remain significant following FDR correction. These findings suggest that temporal gyrus GMV is associated with symptom improvement following CBT in unipolar depression, extending the focus beyond traditionally emphasized limbic regions. Preserved temporal morphology may support cognitive and emotional processes engaged during CBT, underscoring the relevance of temporal cortical structure for understanding the neurobiological correlates of psychotherapy response.
- Open Access
- 7 October 2026
- Published by Springer Nature in Mindfulness
- p. 1-12
Neural Correlates of Dissociating Mindfulness Subdomains: A Differential Analysis Approach
Objectives: In recent years, mindfulness has entered the scientific discourse, holding significant therapeutic potential. However, findings regarding its neurobiological basis have been inconsistent. Trait mindfulness comprises distinct dimensions, two of them are presence and acceptance, but neural correlates accompanying them remain largely underexplored. This study focuses on neurostructural associations reflecting these two subdomains’ distinct patterns to explore their complex interplay, thereby contributing to a more comprehensive, neural, and psychometrically grounded understanding of mindfulness. Method: Structural MRI scans and acceptance and presence scores on the Freiburg Mindfulness Inventory were analyzed in 261 healthy adults. Correlates of both subdomains, oppositely directed, were investigated through multiple linear regression analyses of grey matter volume (GMV). Threshold-free cluster enhancement (TFCE) corrected whole-brain, and region of interest analyses of the amygdala were conducted. Post-hoc, linear regression analyses were performed to further explore each subdomain. Results: An intriguing dissociation in neurostructural correlates of acceptance and presence was observed: Acceptance correlated positively with GMV in the left rolandic operculum ( k TFCE-FWE = 243, p FWE = 0.02) and the left postcentral gyrus ( k TFCE-FWE = 17, p FWE < 0.05) and negatively with amygdala GMV ( k TFCE-FWE = 40, p FWE = 0.03), while presence correlated negatively with GMV in cortical areas. Conclusions: Acceptance may promote non-judgmental integration of emotional and sensory stimuli, while presence reflects the capacity for sustained, focused attention. To our knowledge, this is the first study addressing the distinct neurostructural correlates of these subdomains, revealing their potential complementary and compensatory roles within mindfulness at both the neurobiological and psychometric levels. Preregistration: This study is not preregistered.
- 7 October 2026
- Published by Springer Nature in Mindfulness
- p. 1-12
Open AccessNeural Correlates of Dissociating Mindfulness Subdomains: A Differential Analysis Approach
Objectives: In recent years, mindfulness has entered the scientific discourse, holding significant therapeutic potential. However, findings regarding its neurobiological basis have been inconsistent. Trait mindfulness comprises distinct dimensions, two of them are presence and acceptance, but neural correlates accompanying them remain largely underexplored. This study focuses on neurostructural associations reflecting these two subdomains’ distinct patterns to explore their complex interplay, thereby contributing to a more comprehensive, neural, and psychometrically grounded understanding of mindfulness. Method: Structural MRI scans and acceptance and presence scores on the Freiburg Mindfulness Inventory were analyzed in 261 healthy adults. Correlates of both subdomains, oppositely directed, were investigated through multiple linear regression analyses of grey matter volume (GMV). Threshold-free cluster enhancement (TFCE) corrected whole-brain, and region of interest analyses of the amygdala were conducted. Post-hoc, linear regression analyses were performed to further explore each subdomain. Results: An intriguing dissociation in neurostructural correlates of acceptance and presence was observed: Acceptance correlated positively with GMV in the left rolandic operculum ( k TFCE-FWE = 243, p FWE = 0.02) and the left postcentral gyrus ( k TFCE-FWE = 17, p FWE < 0.05) and negatively with amygdala GMV ( k TFCE-FWE = 40, p FWE = 0.03), while presence correlated negatively with GMV in cortical areas. Conclusions: Acceptance may promote non-judgmental integration of emotional and sensory stimuli, while presence reflects the capacity for sustained, focused attention. To our knowledge, this is the first study addressing the distinct neurostructural correlates of these subdomains, revealing their potential complementary and compensatory roles within mindfulness at both the neurobiological and psychometric levels. Preregistration: This study is not preregistered.
- 19 May 2026
- Published by Hogrefe Publishing Group in Vasa
Trametinib for the treatment of advanced stage patients with arterio-venous malformations
Summary: Background: Arterio-venous malformations (AVMs) may lead to vessel aneurysms and thus to life-threatening bleeding or malperfusion of the extremities, causing recurrent ulceration. Possible therapies are embolisation and/or resection. This study investigates treatment options for patients with AVM Schobinger stage III and IV for whom embolisation and resection are no longer possible and medical treatment with trametinib, a mitogen-activated protein kinase inhibitor (MEK) was performed. Patients and methods: As part of the German guideline development process for the diagnosis and treatment of vascular malformations (AWMF register number 003-007), a systematic literature search was performed using a professional service provider, followed by a retrospective, exploratory analysis based on a consecutive local registry at an interdisciplinary tertiary care center for vascular anomalies. All patients with AVM Schobinger stage IIII – IV were included. Results: Of the 559 reports on specific medications for vascular malformations, only 4 (0.7%) included treatment with trametinib, and only 2 (0.4%) of them addressed its use in AVMs showing reduced blood inflow in the malformation or volume reduction. In our case series of 99 consecutive patients with AVM Schobinger stage III–IV, nine were treated with trametinib. Out of them, 6/9 (66%) had ulceration. 1/6 (20% of the patients with ulceration died, one patient required major amputation, and 4 (60%) were healed without recurrence through treatment. Three patients with chronic pain showed reduced symptoms without requiring additional analgesics. Conclusions: The single cases found in the literature and our small case series suggest that MEK1-inhibitors, such as trametinib, are an option for treating AVM Schobinger stage III – IV. Further large-scale studies are required to confirm these initial observations and to fully explore the potential of MEK1-inhibitors.
- 19 May 2026
- Published by Hogrefe Publishing Group in Vasa
Trametinib for the treatment of advanced stage patients with arterio-venous malformations
Summary: Background: Arterio-venous malformations (AVMs) may lead to vessel aneurysms and thus to life-threatening bleeding or malperfusion of the extremities, causing recurrent ulceration. Possible therapies are embolisation and/or resection. This study investigates treatment options for patients with AVM Schobinger stage III and IV for whom embolisation and resection are no longer possible and medical treatment with trametinib, a mitogen-activated protein kinase inhibitor (MEK) was performed. Patients and methods: As part of the German guideline development process for the diagnosis and treatment of vascular malformations (AWMF register number 003-007), a systematic literature search was performed using a professional service provider, followed by a retrospective, exploratory analysis based on a consecutive local registry at an interdisciplinary tertiary care center for vascular anomalies. All patients with AVM Schobinger stage IIII – IV were included. Results: Of the 559 reports on specific medications for vascular malformations, only 4 (0.7%) included treatment with trametinib, and only 2 (0.4%) of them addressed its use in AVMs showing reduced blood inflow in the malformation or volume reduction. In our case series of 99 consecutive patients with AVM Schobinger stage III–IV, nine were treated with trametinib. Out of them, 6/9 (66%) had ulceration. 1/6 (20% of the patients with ulceration died, one patient required major amputation, and 4 (60%) were healed without recurrence through treatment. Three patients with chronic pain showed reduced symptoms without requiring additional analgesics. Conclusions: The single cases found in the literature and our small case series suggest that MEK1-inhibitors, such as trametinib, are an option for treating AVM Schobinger stage III – IV. Further large-scale studies are required to confirm these initial observations and to fully explore the potential of MEK1-inhibitors.
- Open Access
- 10 May 2026
- Published by Wiley in Movement Disorders
- Vol. 41 (8) , 2143-2154
A Severity‐Agnostic Atrophy Pattern in Spinocerebellar Ataxia Type 3: Volumetrics from ENIGMA ‐Ataxia
Background: Spinocerebellar ataxia type 3 (SCA3) is a rare, inherited neurodegenerative disease characterized by progressive loss of motor coordination. Objectives: We undertook a multisite magnetic resonance imaging study to profile the spatial spread of atrophy across the brain, determine whether atrophy preferentially maps onto specific functional networks, and investigate the relationship between cerebellar and cerebral atrophy. Methods: Whole‐brain grey and white matter (GM and WM) voxel‐based morphometry was performed on 408 individuals with SCA3 (82 pre‐ataxic) and 293 controls. The SCA3 cohort was stratified by ataxia severity to study progression. Cerebellar GM atrophy was mapped onto a task‐based functional atlas. Cerebrocerebellar volumetric covariance was assessed to determine whether cerebral and cerebellar atrophy were coupled. Results: The atrophy pattern is spatially consistent but progressive in magnitude across the disease course. The greatest atrophy (Cohen's d > 1.5) occurred in the pons, cerebellar WM, and cerebellar peduncles; correlations with ataxia severity and duration were also strongest (−0.4 > r > −0.65) in those regions. Cerebellar GM atrophy was greatest ( d ≅ 0.7) in functional regions associated with motor planning/execution, attention, and emotional processing. Sparse cerebral cortical atrophy appears only in the most severe disease subgroup, while striatal atrophy begins in the earliest stages but does not worsen with increasing clinical severity. Reduced cerebrocerebellar volumetric covariance is observed in SCA3 participants versus controls. Conclusions: Cerebellar and brainstem atrophy underlies greater ataxia severity in SCA3, but the spatial pattern of structural changes remains relatively consistent across the course of the disease. Cerebellar GM atrophy is spatially non‐uniform, and occurs maximally in regions consistent with the motor and cognitive clinical presentation of SCA3. Cerebellar atrophy is not mirrored by corresponding cerebral structural changes. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
- 10 May 2026
- Published by Wiley in Movement Disorders
- Vol. 41 (8) , 2143-2154
Open AccessA Severity‐Agnostic Atrophy Pattern in Spinocerebellar Ataxia Type 3: Volumetrics from ENIGMA ‐Ataxia
Background: Spinocerebellar ataxia type 3 (SCA3) is a rare, inherited neurodegenerative disease characterized by progressive loss of motor coordination. Objectives: We undertook a multisite magnetic resonance imaging study to profile the spatial spread of atrophy across the brain, determine whether atrophy preferentially maps onto specific functional networks, and investigate the relationship between cerebellar and cerebral atrophy. Methods: Whole‐brain grey and white matter (GM and WM) voxel‐based morphometry was performed on 408 individuals with SCA3 (82 pre‐ataxic) and 293 controls. The SCA3 cohort was stratified by ataxia severity to study progression. Cerebellar GM atrophy was mapped onto a task‐based functional atlas. Cerebrocerebellar volumetric covariance was assessed to determine whether cerebral and cerebellar atrophy were coupled. Results: The atrophy pattern is spatially consistent but progressive in magnitude across the disease course. The greatest atrophy (Cohen's d > 1.5) occurred in the pons, cerebellar WM, and cerebellar peduncles; correlations with ataxia severity and duration were also strongest (−0.4 > r > −0.65) in those regions. Cerebellar GM atrophy was greatest ( d ≅ 0.7) in functional regions associated with motor planning/execution, attention, and emotional processing. Sparse cerebral cortical atrophy appears only in the most severe disease subgroup, while striatal atrophy begins in the earliest stages but does not worsen with increasing clinical severity. Reduced cerebrocerebellar volumetric covariance is observed in SCA3 participants versus controls. Conclusions: Cerebellar and brainstem atrophy underlies greater ataxia severity in SCA3, but the spatial pattern of structural changes remains relatively consistent across the course of the disease. Cerebellar GM atrophy is spatially non‐uniform, and occurs maximally in regions consistent with the motor and cognitive clinical presentation of SCA3. Cerebellar atrophy is not mirrored by corresponding cerebral structural changes. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
- Open Access
- 4 May 2026
- Published by Elsevier in Brain Research Bulletin
- Vol. 240, 111920
Getting in touch with ourselves: Self-Compassion is associated with subcortical brain structures
- 4 May 2026
- Published by Elsevier in Brain Research Bulletin
- Vol. 240, 111920
Open AccessGetting in touch with ourselves: Self-Compassion is associated with subcortical brain structures
- Open Access
- 19 March 2026
- Published by SAGE Publications in Journal of Neuromuscular Diseases
- Vol. 13 (6) , 1275-1284
Semi-quantitative analyses of muscle magnetic resonance imaging for pattern recognition in early idiopathic inflammatory myopathies
Background: Idiopathic inflammatory myopathies (IIM) are a group of autoimmune diseases characterized by skeletal muscle inflammation. Magnetic resonance imaging (MRI) is increasingly used in IIM diagnosis, yet standardized protocols and comprehensive datasets remain limited. This study aimed to characterize MRI findings across IIM subtypes, identify muscle involvement patterns, and assess correlations between imaging abnormalities and clinical severity. Methods: In this retrospective cohort study, 34 patients with IIM evaluated between 2012 and 2020 in Düsseldorf and Halle (Germany) were included: Inclusion Body Myositis (IBM, n = 9), Dermatomyositis (DM, n = 5), Polymyositis (PM, n = 6), Anti-Synthetase Syndrome (ASYS, n = 5), and Immune-mediated Necrotizing Myopathy (IMNM, n = 9). Clinical data (autoantibody status, creatine kinase [CK] levels, and muscle strength via Manual-Muscle-Testing-8 [MMT-8]) and muscle MRI findings were analysed. Muscle involvement patterns were characterized, and associations with clinical severity were evaluated using univariate linear regression. Results: MRI abnormalities were evident even in early disease stages (median disease duration: 7 months [IQR: 2–18]). Patterns of muscle involvement differed markedly across IIM subtypes; notably, ASYS and IBM showed minimal involvement of upper extremities. A significant correlation was found between MRI-visible pathology and MMT-8 scores (p = 0.027) as well as CK levels (p = 0.028). Conclusion: MRI reveals subclinical muscle involvement in early IIM and uncovers subtype-specific patterns. Given the heterogeneity of MRI findings, individualized imaging approaches are warranted. While MRI serves as a valuable adjunct in diagnosis and management of IIM, its utility depends on standardized protocols and integration with clinical and laboratory data to enable accurate interpretation and informed decision-making in clinical practice.
- 19 March 2026
- Published by SAGE Publications in Journal of Neuromuscular Diseases
- Vol. 13 (6) , 1275-1284
Open AccessSemi-quantitative analyses of muscle magnetic resonance imaging for pattern recognition in early idiopathic inflammatory myopathies
Background: Idiopathic inflammatory myopathies (IIM) are a group of autoimmune diseases characterized by skeletal muscle inflammation. Magnetic resonance imaging (MRI) is increasingly used in IIM diagnosis, yet standardized protocols and comprehensive datasets remain limited. This study aimed to characterize MRI findings across IIM subtypes, identify muscle involvement patterns, and assess correlations between imaging abnormalities and clinical severity. Methods: In this retrospective cohort study, 34 patients with IIM evaluated between 2012 and 2020 in Düsseldorf and Halle (Germany) were included: Inclusion Body Myositis (IBM, n = 9), Dermatomyositis (DM, n = 5), Polymyositis (PM, n = 6), Anti-Synthetase Syndrome (ASYS, n = 5), and Immune-mediated Necrotizing Myopathy (IMNM, n = 9). Clinical data (autoantibody status, creatine kinase [CK] levels, and muscle strength via Manual-Muscle-Testing-8 [MMT-8]) and muscle MRI findings were analysed. Muscle involvement patterns were characterized, and associations with clinical severity were evaluated using univariate linear regression. Results: MRI abnormalities were evident even in early disease stages (median disease duration: 7 months [IQR: 2–18]). Patterns of muscle involvement differed markedly across IIM subtypes; notably, ASYS and IBM showed minimal involvement of upper extremities. A significant correlation was found between MRI-visible pathology and MMT-8 scores (p = 0.027) as well as CK levels (p = 0.028). Conclusion: MRI reveals subclinical muscle involvement in early IIM and uncovers subtype-specific patterns. Given the heterogeneity of MRI findings, individualized imaging approaches are warranted. While MRI serves as a valuable adjunct in diagnosis and management of IIM, its utility depends on standardized protocols and integration with clinical and laboratory data to enable accurate interpretation and informed decision-making in clinical practice.
- 1 March 2026
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 318 (3) , e251386
Identification of Biological Subtypes of Friedreich Ataxia with Structural MRI-based Machine Learning
Using a machine learning approach, three distinct structural MRI–based biological subtypes of Friedreich ataxia were identified, with different patterns of brain degeneration and associations with clinical severity.
- 1 March 2026
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 318 (3) , e251386
Identification of Biological Subtypes of Friedreich Ataxia with Structural MRI-based Machine Learning
Using a machine learning approach, three distinct structural MRI–based biological subtypes of Friedreich ataxia were identified, with different patterns of brain degeneration and associations with clinical severity.
- 2 January 2026
- Published by Springer Nature
- p. 117-126
From Action to Anatomy - Countering Data Scarcity with Video-Based Training for Ill-Posed MRI Problems
- 2 January 2026
- Published by Springer Nature
- p. 117-126
From Action to Anatomy - Countering Data Scarcity with Video-Based Training for Ill-Posed MRI Problems
- Open Access
- 8 December 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
Multimodal Diagnostics in Post-COVID: protocol of a matched-pair case-control study (Preprint)
- 8 December 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
Open AccessMultimodal Diagnostics in Post-COVID: protocol of a matched-pair case-control study (Preprint)
- Open Access
- 27 November 2025
- Published by Elsevier in NeuroImage
- Vol. 324, 121625
Divergent neural correlates of intolerance of uncertainty subdimensions: Insights from multimodal analyses of reward processing
- 27 November 2025
- Published by Elsevier in NeuroImage
- Vol. 324, 121625
Open AccessDivergent neural correlates of intolerance of uncertainty subdimensions: Insights from multimodal analyses of reward processing